falsefalse

EGFR Therapy Evolution: Resistance Mechanisms, Combination Strategies, and Advanced Testing

, , ,

Peer Exchange | <b>Latest Advances in ALK-Positive and BRAF-Positive V600E NSCLC: Efficacy Updates, Brain Metastases Management, and Optimal Treatment Sequencing </b>

Panelists discuss how recent insights into delayed resistance mechanisms in EGFR-positive cancers, including the role of combination therapies and improved testing methods, are shaping strategies to better manage and overcome resistance.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    1. Have you learned anything new since like at least EGFR and have you had combinations. That delayed resistance. How about testing and how about impacting resistance?
    2. Resistance

    Related Content:

    Leveraging ctDNA Platforms in High-Risk Patients: Current Applications and Future Potential
    Translating Metastatic Insights to Early-Stage Management: Current Practices and Future Direction
    Future Directions in ALK-Positive and BRAF-Positive NSCLC Management
    x